Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1963 1
1965 4
1966 2
1967 6
1968 3
1969 6
1970 4
1971 4
1972 2
1973 3
1974 3
1975 4
1976 2
1977 4
1978 3
1979 3
1980 1
1981 3
1982 8
1983 6
1984 5
1985 6
1986 8
1987 8
1988 6
1989 9
1990 6
1991 4
1992 4
1993 3
1994 10
1995 11
1996 6
1997 9
1998 7
1999 6
2000 7
2001 15
2002 12
2003 16
2004 16
2005 19
2006 31
2007 32
2008 46
2009 33
2010 51
2011 53
2012 70
2013 77
2014 76
2015 67
2016 81
2017 80
2018 79
2019 94
2020 103
2021 111
2022 82
2023 71
2024 48
2025 40
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,411 results

Results by year

Filters applied: . Clear all
Page 1
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial.
Smolen JS, Mikuls TR, Galloway J, Müller-Ladner U, Curtis JR, Hashimoto M, Takeuchi T, Choy E, Tanaka Y, Cara C, Lauwerys B, Tilt N, Ufuktepe B, Taylor PC. Smolen JS, et al. Among authors: curtis jr. RMD Open. 2026 Jan 30;12(1):e006094. doi: 10.1136/rmdopen-2025-006094. RMD Open. 2026. PMID: 41617358 Free article. Clinical Trial.
TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy.
Shaikh FS, Shanta MA, Singh AK, Daniels AM, Khuder SA, Thiele GM, Reed GW, Kremer JM, Pappas DA, Curtis JR, O'Dell JR, Ouseph MM, Fox DA, Ahmed S. Shaikh FS, et al. Among authors: curtis jr. Cell Mol Immunol. 2026 Jan 30. doi: 10.1038/s41423-026-01386-y. Online ahead of print. Cell Mol Immunol. 2026. PMID: 41611908
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial.
Tesser JRP, Crowley AR, Box EJ, June JP, Wickersham PB, Valenzuela GJ, Gaylis NB, Lam GKW, Pacheco LA, Ridley DJ, Pinto-Patarroyo GP, Novack SN, Churchill MA, Kohler M, Lee EC, Pando JA, Parris GR, Peterson JR, Shah T, Singhal AK, Vuong V, Levine YA, Evangelista ML, Derosier AA, Curtis JR, Richardson RM, Chernoff D. Tesser JRP, et al. Among authors: curtis jr. Nat Med. 2026 Jan;32(1):369-378. doi: 10.1038/s41591-025-04114-7. Epub 2025 Dec 22. Nat Med. 2026. PMID: 41429981 Free PMC article. Clinical Trial.
1,411 results